These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29328653)

  • 1. Extending Half Life of H-Ferritin Nanoparticle by Fusing Albumin Binding Domain for Doxorubicin Encapsulation.
    Wang C; Zhang C; Li Z; Yin S; Wang Q; Guo F; Zhang Y; Yu R; Liu Y; Su Z
    Biomacromolecules; 2018 Mar; 19(3):773-781. PubMed ID: 29328653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High hydrostatic pressure encapsulation of doxorubicin in ferritin nanocages with enhanced efficiency.
    Wang Q; Zhang C; Liu L; Li Z; Guo F; Li X; Luo J; Zhao D; Liu Y; Su Z
    J Biotechnol; 2017 Jul; 254():34-42. PubMed ID: 28591619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Encoding Albumin Binding into Chemotherapeutic-loaded Polypeptide Nanoparticles Enhances Their Antitumor Efficacy.
    Yousefpour P; McDaniel JR; Prasad V; Ahn L; Li X; Subrahmanyan R; Weitzhandler I; Suter S; Chilkoti A
    Nano Lett; 2018 Dec; 18(12):7784-7793. PubMed ID: 30461287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL.
    Li R; Yang H; Jia D; Nie Q; Cai H; Fan Q; Wan L; Li L; Lu X
    J Control Release; 2016 Apr; 228():96-106. PubMed ID: 26951928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein.
    Hopp J; Hornig N; Zettlitz KA; Schwarz A; Fuss N; Müller D; Kontermann RE
    Protein Eng Des Sel; 2010 Nov; 23(11):827-34. PubMed ID: 20817756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-binding domain extends half-life of glucagon-like peptide-1.
    Tan H; Su W; Zhang W; Zhang J; Sattler M; Zou P
    Eur J Pharmacol; 2021 Jan; 890():173650. PubMed ID: 33049303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements.
    Falvo E; Tremante E; Arcovito A; Papi M; Elad N; Boffi A; Morea V; Conti G; Toffoli G; Fracasso G; Giacomini P; Ceci P
    Biomacromolecules; 2016 Feb; 17(2):514-22. PubMed ID: 26686226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α
    Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
    J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects.
    Yang H; Feng Y; Cai H; Jia D; Li H; Tao Z; Zhong Y; Li Z; Shi Q; Wan L; Li L; Lu X
    Theranostics; 2018; 8(9):2459-2476. PubMed ID: 29721092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteins.
    Cantante C; Lourenço S; Morais M; Leandro J; Gano L; Silva N; Leandro P; Serrano M; Henriques AO; Andre A; Cunha-Santos C; Fontes C; Correia JDG; Aires-da-Silva F; Goncalves J
    J Biotechnol; 2017 Jul; 253():23-33. PubMed ID: 28549690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and biological evaluation of novel long-acting adalimumab Fab conjugated with the albumin binding domain.
    Zhang Q; Qian M; Wu Y; Wang Y; Shangguan W; Lu J; Zhao W; Feng J
    Eur J Pharmacol; 2021 Aug; 904():174152. PubMed ID: 33964292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin.
    Yousefpour P; Ahn L; Tewksbury J; Saha S; Costa SA; Bellucci JJ; Li X; Chilkoti A
    Small; 2019 Mar; 15(12):e1804452. PubMed ID: 30756483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis.
    Yin S; Liu Y; Dai S; Zhang B; Qu Y; Zhang Y; Choe WS; Bi J
    Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem fusion of albumin-binding domains promoted soluble expression and stability of recombinant trichosanthin in vitro and in vivo.
    Ren Z; Zhao J; Cao X; Wang F
    Protein Expr Purif; 2022 Dec; 200():106147. PubMed ID: 35917982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
    Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
    Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting.
    Jiang B; Jia X; Ji T; Zhou M; He J; Wang K; Tian J; Yan X; Fan K
    Sci China Life Sci; 2022 Feb; 65(2):328-340. PubMed ID: 34482518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat sensitive E-helix cut ferritin nanocages for facile and high-efficiency loading of doxorubicin.
    Xia H; Xu H; Wang J; Wang C; Chen R; Tao T; Xu S; Zhang J; Ma K; Wang J
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126973. PubMed ID: 37729988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a long-acting ciliary neurotrophic factor via genetically fused with an albumin-binding domain.
    Xu L; Zhang C; Liu L; Zhang Y; Wang Q; Wang J; Liu Y; Su Z
    Protein Expr Purif; 2017 Nov; 139():14-20. PubMed ID: 28711730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
    Liang M; Fan K; Zhou M; Duan D; Zheng J; Yang D; Feng J; Yan X
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14900-5. PubMed ID: 25267615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion with an albumin-binding domain improves pharmacokinetics of an αvβ3-integrin binding fibronectin scaffold protein.
    Gapizov SS; Petrovskaya LE; Shingarova LN; Kryukova EA; Boldyreva EF; Lukashev EP; Yakimov SA; Svirshchevskaya EV; Dolgikh DA; Kirpichnikov MP
    Biotechnol Appl Biochem; 2019 Jul; 66(4):617-625. PubMed ID: 31140614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.